Selecting appropriate inhalers based on individual characteristics and shared decision-making is crucial for optimizing care for patients with COPD. Jeffrey D. Dunn ...

PARMA, Italy, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Today, Chiesi Farmaceutici, an international research-focused healthcare group (Chiesi Group), announced the results of two studies published in The ...

Please provide your email address to receive an email when new articles are posted on . Compared with a dual therapy inhaler, a triple therapy inhaler improved inspiratory capacity in those with COPD.

Among patients with chronic obstructive pulmonary disease who received prior treatment with multiple-inhaler triple therapy, single-inhaler triple therapy was effective in improving health status and ...

CHICAGO -- A fixed-dose inhaler combining an inhaled corticosteroid, long-acting muscarinic antagonist, and long-acting beta agonist (ICS/LAMA/LABA) improved lung function and reduced exacerbations in ...

The FDA approved United Kingdom-based GlaxoSmithKline’s Trelegy Ellipta, a once-daily inhaler that contains three medicines for chronic obstructive pulmonary disease. The inhaler, developed with the ...

PHILADELPHIA, Pennsylvania — A simple handheld training device doubles the likelihood that patients with asthma will achieve the correct inspiratory flow when using their medication inhalers. After ...

HONOLULU -- Although single maintenance and reliever therapy (SMART, or MART) marks a new chapter in asthma treatment, its advocates acknowledged practical limitations during a debate at the CHEST ...

People with chronic obstructive pulmonary disease (COPD) often need to use many different inhalers every day to help them breathe better. But now, there are newer inhalers that combine different ...

TIRUCHY: For 8-year-old Gowtham of Marsingpet, even a mild cough can make it a breathless night. Though doctors have prescribed him an inhaler, his mother is reluctant to give it him fearing it will ...

SAN FRANCISCO (MarketWatch) -- AstraZeneca PLC said Monday that results from a one-year study show that patients taking its Symbicort single-inhaler therapy had fewer asthma attacks and required less ...

Asthma patients in South Carolina are being confronted with a critical development: the departure of the widely used inhaler, Flovent, from pharmacy shelves. This shift, initiated by manufacturer GSK, ...